Non-CE Satellite Symposia: Nursing Considerations for Asparlas: A More Stable PEGylated Asparaginase Molecule (SYM3)
6:45 – 8:00 am
Thursday, September 15 Non-CNE Symposia
Thursday, September 15 Non-CNE Symposia
Nurses will learn about ASPARLAS, a longer-lasting PEGylated asparaginase option that can be used in a multi-agent chemotherapeutic regimen to treat pediatric patients with ALL.
We thank Servier for their generous support of this event.
Tagged under
Related items
- Non-CE Satellite Symposia: Optimizing Iron Chelation in Sickle Cell Disease Management From Pediatric Through Adult Care: East Coast and West Coast Perspectives (SYM6)
- Non-CE Satellite Symposia: VOD/SOS with Renal and Pulmonary Dysfunction Following HSCT in a Pediatric Patient with Relapsed ALL (SYM5)
- Non-CE Satellite Symposia: The Only Recombinant Erwinia Asparaginase Approved for the Treatment of ALL/LBL (SYM4)
- Satellite Symposia: Embracing Targeted Medical Therapies in Neurofibromatosis Type 1 — Practical Principles for the Pediatric Hematology/Oncology Nurse (SYM2)